We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
-4.48%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.5B
AUM Growth
-$1.68B
Cap. Flow
-$4.46B
Cap. Flow %
-30.76%
Top 10 Hldgs %
17.42%
Holding
749
New
70
Increased
222
Reduced
165
Closed
75

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$66.1M
2
HLT icon
Hilton Worldwide
HLT
+$60.8M
3
ALKS icon
Alkermes
ALKS
+$47.3M
4
APTV icon
Aptiv
APTV
+$47M
5
ABBV icon
AbbVie
ABBV
+$44.8M

Sector Composition

Rank Sector Weight
1 Technology 11.41%
2 Healthcare 10.86%
3 Financials 8.97%
4 Consumer Discretionary 8.6%
5 Industrials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLL
176
DELISTED
L3 Technologies, Inc.
LLL
$10.2M 0.07%
97,931
-2,077
-2% -$234K
DFS
177
DELISTED
Discover Financial Services
DFS
$10.2M 0.07%
195,974
+3,117
+2% +$171K
DUK icon
178
Duke Energy
DUK
$102B
$10.1M 0.07%
140,282
-176
-0.1% -$12.7K
BNY
179
Bank of New York Mellon
BNY
$108B
$9.64M 0.07%
246,248
-10,829
-4% -$450K
SPNC
180
DELISTED
Spectranetics Corp
SPNC
$9.55M 0.07%
810,260
+384,850
+90% +$6.89M
TMO icon
181
Thermo Fisher Scientific
TMO
$211B
$9.41M 0.06%
76,957
+27
+0% +$3.52K
VRNT
182
DELISTED
Verint Systems
VRNT
$9.1M 0.06%
413,928
-6,282
-1% -$174K
WPXP
183
DELISTED
WPX Energy, Inc.
WPXP
$8.86M 0.06%
+240,000
New +$9.57M
BMY icon
184
Bristol-Myers Squibb
BMY
$127B
$8.71M 0.06%
147,112
+50
+0% +$3.17K
GS icon
185
Goldman Sachs
GS
$313B
$8.66M 0.06%
49,847
-1,302
-3% -$255K
ELV icon
186
Elevance Health
ELV
$81.9B
$8.46M 0.06%
60,467
-166
-0.3% -$24.9K
THRM icon
187
Gentherm
THRM
$1.31B
$8.33M 0.06%
185,385
+43,550
+31% +$2.09M
DWRE
188
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$8.33M 0.06%
161,100
+51,600
+47% +$3.19M
ESRX
189
DELISTED
Express Scripts Holding Company
ESRX
$8.09M 0.06%
99,910
-2,815
-3% -$245K
COP icon
190
ConocoPhillips
COP
$147B
$8M 0.06%
166,861
-3,459
-2% -$176K
DGI
191
DELISTED
DigitalGlobe Inc.
DGI
$7.99M 0.06%
419,915
+79,730
+23% +$1.89M
VEEV icon
192
Veeva Systems
VEEV
$30.3B
$7.87M 0.05%
336,306
+8,612
+3% +$224K
PSX icon
193
Phillips 66
PSX
$82.9B
$7.84M 0.05%
102,061
+3,326
+3% +$264K
SO icon
194
Southern Company
SO
$110B
$7.81M 0.05%
174,805
-3,743
-2% -$164K
SPG icon
195
Simon Property Group
SPG
$74.5B
$7.73M 0.05%
42,099
+16
+0% +$2.93K
MON
196
DELISTED
Monsanto Co
MON
$7.62M 0.05%
89,242
+30
+0% +$2.96K
PKG icon
197
Packaging Corp of America
PKG
$22.7B
$7.53M 0.05%
125,192
-3,279
-3% -$219K
USB icon
198
US Bancorp
USB
$99.6B
$7.53M 0.05%
183,590
-3,040
-2% -$132K
MMM icon
199
3M
MMM
$89B
$7.41M 0.05%
62,535
+20
+0% +$2.46K
PRU icon
200
Prudential Financial
PRU
$41.7B
$7.35M 0.05%
96,494
+29
+0% +$2.43K

Similar funds

Calamos Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Calamos Advisors held 749 positions worth $14.5B, down 10% from $16.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Calamos Advisors withdrew a net $4.46B in Q3 2015, closing 75 positions and reducing 165 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $280M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Calamos Advisors opened a new position in HCA Healthcare worth $57.7M.

  • Calamos Advisors's largest Q3 2015 buy was HCA Healthcare: 746,298 shares worth $57.7M.
  • Calamos Advisors added most to Alkermes in Q3 2015, an estimated $47.3M increase.
  • Calamos Advisors's biggest Q3 2015 reduction was Apple, cutting an estimated $144M.
  • Calamos Advisors fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $280M.
  • Calamos Advisors's ten largest holdings make up 17% of its $14.5B portfolio in Q3 2015.
  • Calamos Advisors opened 70 new positions and closed 75 in Q3 2015.
  • Calamos Advisors's portfolio value fell 10% quarter-over-quarter to $14.5B.

Based on Calamos Advisors's 13F filing for Q3 2015, filed 10 Nov 2015.